Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
Recruiting
Phase 3
Interventional Study
Analgesic Efficacy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 80 (estimated)
- Sponsor
- Wake Forest University Health Sciences · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Local anesthetic infiltration is a primary source of acute pain during stereotactic procedures.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients scheduled for a standard of care procedure requiring a stereotactic head frame to be placed
Exclusion Criteria:
* Patients not scheduled for a standard of care procedure requiring a stereotactic head frame to be placed will not be approached
Contacts